Endurance Wealth Management’s GSK GSK Stock Holding History

Endurance Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$21K	Hold	587	–	–	﹤0.01%	420
2023 Q1	$21K	Hold	587	–	–	﹤0.01%	428
2022 Q4	$21K	Hold	587	–	–	﹤0.01%	409
2022 Q3	$17K	Hold	587	–	–	﹤0.01%	423
2022 Q2	$32K	Hold	587	–	–	﹤0.01%	370
2022 Q1	$32K	Hold	587	–	–	﹤0.01%	399
2021 Q4	$32K	Hold	587	–	–	﹤0.01%	397
2021 Q3	$28K	Hold	587	–	–	﹤0.01%	414
2021 Q2	$29K	Hold	587	–	–	﹤0.01%	411
2021 Q1	$26K	Hold	587	–	–	﹤0.01%	427
2020 Q4	$27K	Hold	587	–	–	﹤0.01%	382
2020 Q3	$28K	Hold	587	–	–	﹤0.01%	361
2020 Q2	$30K	Hold	587	–	–	﹤0.01%	362
2020 Q1	$28K	Buy	587 +160	+37%	+$8.54K	0.01%	336
2019 Q4	$25K	Hold	427	–	–	﹤0.01%	340
2019 Q3	$23K	Hold	427	–	–	﹤0.01%	345
2019 Q2	$21K	Hold	427	–	–	﹤0.01%	333
2019 Q1	$22K	Hold	427	–	–	﹤0.01%	323
2018 Q4	$20K	Sell	427 -115	-21%	-$5.66K	﹤0.01%	316
2018 Q3	$27K	Hold	542	–	–	﹤0.01%	316
2018 Q2	$27K	Sell	542 -68	-11%	-$3.42K	﹤0.01%	319
2018 Q1	$30K	Hold	610	–	–	0.01%	323
2017 Q4	$27K	Sell	610 -104	-15%	-$4.8K	﹤0.01%	317
2017 Q3	$36K	Hold	714	–	–	0.01%	295
2017 Q2	$39K	Hold	714	–	–	0.01%	295
2017 Q1	$38K	Hold	714	–	–	0.01%	294
2016 Q4	$34K	Hold	714	–	–	0.01%	298
2016 Q3	$38K	Sell	714 -93	-12%	-$5.1K	0.01%	288
2016 Q2	$44K	Hold	807	–	–	0.01%	269
2016 Q1	$41	Hold	807	–	–	0.01%	278
2015 Q4	$41K	Sell	807 -61	-7%	-$3.11K	0.01%	284
2015 Q3	$44K	Hold	868	–	–	0.01%	283
2015 Q2	$45K	Buy	+868	New	+$48.9K	0.01%	282

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Endurance Wealth Management's GSK Position: Q2 2023 in Review

Endurance Wealth Management held its GSK (GSK) position steady in Q2 2023 at 587 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

Endurance Wealth Management first reported a position in GSK in Q2 2015 and has held it in 33 quarters since. The position peaked at $45K in Q2 2015. 828 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Endurance Wealth Management held 587 shares of GSK worth $21K as of Q2 2023.
Endurance Wealth Management left its GSK share count unchanged in Q2 2023.
GSK made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #420 holding.
Endurance Wealth Management first reported a position in GSK in Q2 2015 and has held it in 33 quarters since.
Endurance Wealth Management's GSK position peaked at $45K in Q2 2015.
828 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.